Eytan Mor

2.2k total citations
47 papers, 1.7k citations indexed

About

Eytan Mor is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Eytan Mor has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Surgery, 31 papers in Hepatology and 13 papers in Epidemiology. Recurrent topics in Eytan Mor's work include Organ Transplantation Techniques and Outcomes (31 papers), Liver Disease and Transplantation (26 papers) and Liver Disease Diagnosis and Treatment (12 papers). Eytan Mor is often cited by papers focused on Organ Transplantation Techniques and Outcomes (31 papers), Liver Disease and Transplantation (26 papers) and Liver Disease Diagnosis and Treatment (12 papers). Eytan Mor collaborates with scholars based in Israel, United States and France. Eytan Mor's co-authors include Irit Meivar‐Levy, Sarah Ferber, Bo S. Husberg, Göran B. Klintmalm, Ziv Ben‐Ari, John F. Gibbs, Robert M. Goldstein, Ran Tur‐Kaspa, Tirza Klein and Anat R. Tambur and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Eytan Mor

47 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eytan Mor Israel 22 1.1k 896 472 322 259 47 1.7k
John P. Leone United States 18 878 0.8× 101 0.1× 197 0.4× 118 0.4× 258 1.0× 56 1.3k
Kun‐Ming Chan Taiwan 26 899 0.8× 1.1k 1.2× 551 1.2× 187 0.6× 26 0.1× 118 1.8k
J Bauditz Germany 16 292 0.3× 246 0.3× 401 0.8× 160 0.5× 276 1.1× 27 1.2k
Francis T. Thomas United States 26 1.0k 0.9× 73 0.1× 122 0.3× 313 1.0× 263 1.0× 49 1.7k
Hector C. Ramos United States 11 698 0.6× 286 0.3× 162 0.3× 86 0.3× 100 0.4× 13 1.3k
Weiqiang Ju China 17 411 0.4× 400 0.4× 261 0.6× 249 0.8× 21 0.1× 74 948
Janeth C. Villanueva United States 18 370 0.3× 458 0.5× 407 0.9× 359 1.1× 56 0.2× 29 1.4k
Filoména Conti France 17 272 0.2× 481 0.5× 331 0.7× 153 0.5× 37 0.1× 35 868
Gregory M. Tiao United States 22 601 0.5× 373 0.4× 152 0.3× 251 0.8× 80 0.3× 59 1.2k
Francesca Gavazzi Italy 19 783 0.7× 128 0.1× 88 0.2× 185 0.6× 212 0.8× 55 1.5k

Countries citing papers authored by Eytan Mor

Since Specialization
Citations

This map shows the geographic impact of Eytan Mor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eytan Mor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eytan Mor more than expected).

Fields of papers citing papers by Eytan Mor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eytan Mor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eytan Mor. The network helps show where Eytan Mor may publish in the future.

Co-authorship network of co-authors of Eytan Mor

This figure shows the co-authorship network connecting the top 25 collaborators of Eytan Mor. A scholar is included among the top collaborators of Eytan Mor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eytan Mor. Eytan Mor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meivar‐Levy, Irit, Michael Gurevich, Eytan Mor, et al.. (2019). The role of the vasculature niche on insulin-producing cells generated by transdifferentiation of adult human liver cells. Stem Cell Research & Therapy. 10(1). 53–53. 10 indexed citations
2.
Nesher, Eviatar, János Winkler, Idan Carmeli, et al.. (2018). Bariatric surgery in solid organ transplant patients: Long-term follow-up results of outcome, safety, and effect on immunosuppression. American Journal of Transplantation. 18(11). 2772–2780. 47 indexed citations
3.
Berneman, Zwi, Eytan Mor, Alessia Fornoni, et al.. (2014). The Temporal and Hierarchical Control of Transcription Factors-Induced Liver to Pancreas Transdifferentiation. PLoS ONE. 9(2). e87812–e87812. 49 indexed citations
4.
Meivar‐Levy, Irit, Tamar Sapir, Tal Weissbach, et al.. (2011). Human Liver Cells Expressing Albumin and Mesenchymal Characteristics Give Rise to Insulin-Producing Cells. SHILAP Revista de lepidopterología. 2011. 1–12. 24 indexed citations
5.
Gefen-Halevi, Shiraz, et al.. (2010). NKX6.1 Promotes PDX-1-Induced Liver to Pancreatic β-Cells Reprogramming. Cellular Reprogramming. 12(6). 655–664. 47 indexed citations
6.
Ben‐Ari, Ziv, Orit Pappo, Smadar Yitzhaki, et al.. (2009). Uridine-5′-triphosphate Protects Against Hepatic- Ischemic/Reperfusion Injury in Mice. Transplantation. 87(8). 1155–1162. 6 indexed citations
7.
Ben‐Ari, Ziv, Eytan Mor, J. Sulkes, et al.. (2005). Cathepsin B inactivation attenuates the apoptotic injury induced by ischemia/reperfusion of mouse liver. APOPTOSIS. 10(6). 1261–1269. 23 indexed citations
8.
Belenky, Alexander, Eytan Mor, Gabriel Bartal, et al.. (2004). Transhepatic Balloon Dilatation of Early Biliary Strictures in Pediatric Liver Transplantation: Successful Initial and Mid-Term Outcome. CardioVascular and Interventional Radiology. 27(5). 491–4. 21 indexed citations
9.
Ben‐Ari, Ziv, Jaqueline Sulkes, N Bar-Nathan, et al.. (2004). Serum cholestasis markers as predictors of early outcome after liver transplantation. Clinical Transplantation. 18(2). 130–136. 46 indexed citations
10.
Shapiro, Rivka, et al.. (2003). Neoral dose monitoring using 2‐hour cyclosporine post‐dose levels in stable children with liver transplants: Improvement in renal function. Pediatric Transplantation. 7(6). 450–453. 3 indexed citations
11.
Mor, Eytan, N Bar-Nathan, E Shaharabani, et al.. (2003). Cholestasis and hypoalbuminemia as predictors of outcome after liver transplantation. Transplantation Proceedings. 35(2). 617–618. 5 indexed citations
12.
Mor, Eytan, et al.. (2001). Cytokine gene polymorphism in liver allograft recipients. Transplantation Proceedings. 33(6). 2941–2942. 6 indexed citations
13.
Mor, Eytan, Orit Pappo, N Bar-Nathan, et al.. (2001). DEFIBROTIDE FOR THE TREATMENT OF VENO-OCCLUSIVE DISEASE AFTER LIVER TRANSPLANTATION. Transplantation. 72(7). 1237–1240. 24 indexed citations
14.
Tambur, Anat R., et al.. (2001). ROLE OF CYTOKINE GENE POLYMORPHISM IN HEPATITIS C RECURRENCE AND ALLOGRAFT REJECTION AMONG LIVER TRANSPLANT RECIPIENTS 1. Transplantation. 71(10). 1475–1480. 69 indexed citations
15.
Mor, Eytan, E Shaharabani, Ziv Ben‐Ari, et al.. (2001). Experience with 100 liver transplant recipients at the Rabin Medical Center and Schneider Children’s Medical Center. Transplantation Proceedings. 33(6). 2943–2944. 1 indexed citations
16.
Bar-Nathan, N, E Shaharabani, A Yussim, et al.. (1999). Hepatic artery thrombosis in pediatric liver transplantation: Graft salvage after thrombectomy. Pediatric Transplantation. 3(1). 74–78. 35 indexed citations
17.
Atillasoy, Evren, Alihan Gürkan, Eytan Mor, et al.. (1998). Cholesterol levels long term after liver transplant. Transplantation Proceedings. 30(5). 2049–2050. 9 indexed citations
18.
Mor, Eytan, N Bar-Nathan, D Shmueli, et al.. (1997). Initial experience with living-related donor liver transplantation in Rabin Medical Center, Israel. Transplantation Proceedings. 29(6). 2633–2634. 2 indexed citations
19.
Solomon, Harvey, Thomas A. Gonwa, Eytan Mor, et al.. (1993). 0KT3 RESCUE FOR STEROID-RESISTANT REJECTION IN ADULT LIVER TRANSPLANTATION. Transplantation. 55(1). 87–91. 30 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John P. Leone Breakdown of academic impact, for papers by Kun‐Ming Chan Breakdown of academic impact, for papers by J Bauditz Breakdown of academic impact, for papers by Francis T. Thomas Breakdown of academic impact, for papers by Hector C. Ramos Breakdown of academic impact, for papers by Weiqiang Ju Breakdown of academic impact, for papers by Janeth C. Villanueva Breakdown of academic impact, for papers by Filoména Conti Breakdown of academic impact, for papers by Gregory M. Tiao Breakdown of academic impact, for papers by Francesca Gavazzi
Rankless by CCL
2026